Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare (NHC) Return on Sales: 2009-2024

Historic Return on Sales for National Healthcare (NHC) over the last 16 years, with FY2024 value amounting to 0.08%.

  • National Healthcare's Return on Sales fell 200.0% to 0.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.08% for FY2024, which is 200.0% up from last year.
  • Per National Healthcare's latest filing, its Return on Sales stood at 0.08% for FY2024, which was up 200.0% from 0.06% recorded in FY2023.
  • National Healthcare's Return on Sales' 5-year high stood at 0.12% during FY2021, with a 5-year trough of 0.02% in FY2022.
  • Over the past 5 years, National Healthcare's median Return on Sales value was 0.06% (recorded in 2023), while the average stood at 0.06%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 900bps in 2021, then crashed by -1100bps in 2022.
  • National Healthcare's Return on Sales (Annual) stood at 0.03% in 2020, then skyrocketed by 313bps to 0.12% in 2021, then tumbled by -85bps to 0.02% in 2022, then skyrocketed by 211bps to 0.06% in 2023, then surged by 37bps to 0.08% in 2024.
  • Its Return on Sales stands at 0.08% for FY2024, versus 0.06% for FY2023 and 0.02% for FY2022.